Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
A scalable ultra-long-acting tenofovir phosphonate prodrug sustains HBV suppression.
Journal: Science advances
Published: August 01, 2025
An Ultra-Long-Acting Dimeric Bictegravir Prodrug Defined by a Short Pharmacokinetic Tail.
Journal: Research square
Published: March 04, 2025
An ultra-long-acting dimeric bictegravir prodrug defined by a short pharmacokinetic tail.
Journal: Nature communications
Published: February 04, 2025
Showing 1-3 of 3
Last Updated: 09/26/2026